Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-14-000727

EVP, CLO, and Secretary gave up 7,193 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELBEL CAESAR J EVP, CLO, and Secretary 2013-12-31 Shares withheld for taxes −7,193 $4.34 $31,218 45,594 D
Derivatives
BELBEL CAESAR J EVP, CLO, and Secretary 2013-12-31 Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…